GokalR.Peritoneal dialysis: Global update.Perit Dial Int1999; 19(Suppl 2): S11–15.
2.
FentonS., DesmeulesM., CoplestonP., ArbusG., FromentD., JefferyJ.Renal replacement therapy in Canada: A report from the Canadian Organ Replacement Register.Am J Kidney Dis1995; 25: 134–50.
3.
FentonS.S., SchaubelD.E., DesmeulesM., MorrisonH.I., MaoY., CoplestonP.Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates.Am J Kidney Dis1997; 30: 334–42.
4.
MaiorcaR., CancariniG., ZubaniR., CameriniC., ManiliL., BrunoriG.CAPD viability: A long-term comparison with hemodialysis.Perit Dial Int1996; 16: 276–87.
5.
MaiorcaR., CancariniG.C.Outcome of peritoneal dialysis: Comparative studies. In: GokalR., NolphK.D., eds. The Textbook of Peritoneal Dialysis.Dordrecht: Kluwer Academic; 1994: 735–50.
6.
ThodisE., PassadakisP., VargemezisV., OreopoulosD.G.Peritoneal dialysis: Better than, equal to, or worse than hemodialysis? Data worth knowing before choosing a dialysis modality.Perit Dial Int2001; 21: 25–35.
7.
OreopoulosD.G.Peritoneal dialysis in the past 20 years: An exciting journey.Perit Dial Int1999; 19(Suppl 3): S6–8.
8.
MaiorcaR., VoneshE.F., CavalliP., De VecchiA., GiangrandeA., La GrecaG.A multicenter, selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis.Perit Dial Int1991; 11: 118–27.
9.
Van BiesenW., VanholderR.C., VeysN., DhondtA., LameireN.H.An evaluation of an integrative care approach for end-stage renal disease patients.J Am Soc Nephrol2000; 11: 116–25.
10.
MaiorcaR., VoneshE., CancariniG.C., CantaluppiA., ManiliL., BrunoriG.A six years comparison of patient and technique survivals in CAPD and HD.Kidney Int1988; 34: 518–24.
11.
WolfeR.A., PortF.K., HawthorneV.M., GuireK.E.A comparison of survival among dialytic therapies of choice: In-center hemodialysis versus continuous ambulatory peritoneal dialysis at home.Am J Kidney Dis1990; 15: 433–40.
12.
FallerB., LameireN.Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years.Nephrol Dial Transplant1994; 9: 280–6.
13.
DaviesS.J., PhillipsL., GriffithsA.M., RussellL.H., NaishP.F., RussellG.I.What really happens to people on long-term peritoneal dialysis?Kidney Int1998; 54: 2207–17.
TeehanB.P., SchleiferC.R., BrownJ.M., SiglerM.H., RaimondoJ.Urea kinetic analysis and clinical outcome on CAPD. A five year longitudinal study.Adv Perit Dial1990; 6: 181–5.
18.
KeshaviahP., NolphK.D.The peak concentration hypothesis: A urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis.Perit Dial Int1989; 9: 257–60.
19.
Canada-USA (CANUSA) Peritoneal Dialysis Study Group.Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcome.J Am Soc Nephrol1996; 7: 198–207.
20.
BlakeP.G., FinkelsteinF.O.Why is the proportion of patients doing peritoneal dialysis declining in North America?Perit Dial Int2001; 21: 107–14.
21.
ChurchillD.N.Outcome studies in adequacy of dialysis.Perit Dial Int1997; 17(Suppl 3): S42–5.
22.
NKF-DOQI Clinical practice guidelines for peritoneal dialysis adequacy.National Kidney Foundation.Am J Kidney Dis1997; 30(3 Suppl 2): S67–136.
23.
II. NKF-K/DOQI Clinical practice guidelines for peritoneal dialysis adequacy: Update 2000.Am J Kidney Dis2001; 37(1 Suppl 1): S65–136.
24.
GokalR.Adequacy, nutrition and outcome in peritoneal dialysis: Is there a link?Semin Dial1997; 10: 94–9.
25.
BlakeP.G.A critique of the Canada/USA (CANUSA) peritoneal dialysis study.Perit Dial Int1996; 16: 243–5.
26.
MakS.K., WongP.N., LoK.Y., TongG.M., FungL.H., WongA.K.Randomized prospective study of the effect of increased dialytic dose on nutritional and clinical outcome in continuous ambulatory peritoneal dialysis patients.Am J Kidney Dis2000; 36: 105–14.
27.
BargmanJ.M., ThorpeK.E., ChurchillD.N.Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study.J Am Soc Nephrol2001; 12: 2158–62.
28.
Paniagua R, Amato D, Vonesh E, Correa–Rotter R, Ramos A, Moran J, et al, for the Mexican Nephrology Collaborative Study Group.Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.J Am Soc Nephrol2002; 13: 1307–20.
29.
MaiorcaR., BrunoriG., ZubaniR., CancariniG.C., ManiliL., CameriniC.Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study.Nephrol Dial Transplant1995; 10: 2295–305.
30.
SzetoC.C., WongT.Y., LeungC.B., WangA.Y., LawM.C., LuiS.F.Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients.Kidney Int2000; 58: 400–7.
31.
SzetoC.C., WongT.Y., ChowK.M., LeungC.B., LawM.C., WangA.Y.Impact of dialysis adequacy on the mortality and morbidity of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis.J Am Soc Nephrol2001; 12: 355–60.
32.
RoccoM., SoucieJ.M., PastanS., McClellanW.M.Peritoneal dialysis adequacy and risk of death.Kidney Int2000; 58: 446–57.
33.
Diaz-BuxoJ.A., LowrieE.G., LewN.L., ZhangH., ZhuX., LazarusJ.M.Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance.Am J Kidney Dis1999; 33: 523–34.
34.
JansenM.A., KorevaarJ.C., DekkerF.W., JagerK.J., BoeschotenE.W., KredietR., for the NECOSAD Study Group. The relationship between Kt/Vurea and nPNA in anuric peritoneal dialysis patients: A comparison with predialysis patients.Perit Dial Int2001; 21: 509–15.
35.
VenkataramanV., NolphK.D.Preservation of residual renal function — an important goal.Perit Dial Int2000; 20: 392–5.
36.
LysaghtM.J., VoneshE.F., GotchF., IbelsL., KeenM., LindholmB.The influence of dialysis treatment modality on the decline of remaining renal function.ASAIO Trans1991; 37: 598–604.
37.
LameireN.H.The impact of residual renal function on the adequacy of peritoneal dialysis.Contrib Nephrol1998; 124: 76–93; Discussion: 93–102.
38.
CaravacaF., ArrobasM., DominguezC.Influence of residual renal function on dietary protein and caloric intake in patients on incremental peritoneal dialysis.Perit Dial Int1999; 19: 350–6.
39.
JonesM.R.Etiology of severe malnutrition: Results of an international cross-sectional study in continuous ambulatory peritoneal dialysis patients.Am J Kidney Dis1994; 23: 412–20.
40.
McCuskerF.X., TeehanB.P., ThorpeK.E., KeshaviahP.R., ChurchillD.N.How much peritoneal dialysis is required for the maintenance of a good nutritional state? Canada–USA (CANUSA) Peritoneal Dialysis Study Group.Kidney Int Suppl1996; 56: S56–61.
41.
HartyJ.C., GokalR.The impact of peritoneal permeability and residual renal function on PD prescription.Perit Dial Int1996; 16(Suppl 1): S147–52.
42.
BergströmJ., FürstP., AlvestrandA., LindholmB.Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis.Kidney Int1993; 44: 1048–57.
43.
KaysenG.A.The microinflammatory state in uremia: Causes and potential consequences.J Am Soc Nephrol2001; 12: 1549–57.
44.
StenvinkelP.Inflammatory and atherosclerotic interactions in the depleted uremic patient.Blood Purif2001; 19: 53–61.
45.
SchomigM., EisenhardtA., RitzE.The microinflammatory state of uremia.Blood Purif2000; 18: 327–32.
46.
BergströmJ., LindholmB.Malnutrition, cardiac disease and mortality — an integrated point of view.Am J Kidney Dis1998; 32: 834–41.
47.
RiellaM.C.Malnutrition in dialysis: Malnourishment or uremic inflammatory response?Kidney Int2000; 57: 1211–32.
48.
StenvinkelP., HeimbürgerO., PaultreF., DiczfalusyU., WangT., BerglundL.Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.Kidney Int1999; 55: 1899–911.
49.
StenvinkelP., HeimbürgerO., LindholmB., KaysenG.A., BergströmJ.Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome).Nephrol Dial Transplant2000; 15: 953–60.
50.
LowrieE.G.Acute-phase inflammatory process contributes to malnutrition, anemia, and possibly other abnormalities in dialysis patients.Am J Kidney Dis1998; 32(6 Suppl 4): S105–12.
51.
WangT., HeimbürgerO., BergströmJ., LindholmB.Optimizing solute clearance and fluid balance with high-fill volumes: Effect of hypertonic dialysate.Am J Kidney Dis1998; 31: 1053–7.
52.
RippeB., StelinG., HaraldssonB.Computer simulations of peritoneal fluid transport in CAPD.Kidney Int1991; 40: 315–25.
53.
RippeB., KredietR.Peritoneal physiology—transport of solutes. In: GokalR., NolphK., eds. The Textbook of Peritoneal Dialysis.Dordrecht: Kluwer Academic; 1994: 69–113.
54.
KredietR.T., BoeschotenE.W., StruijkD.G., AriszL.Differences in the peritoneal transport of water, solutes and proteins between dialysis with two- and with three-litre exchanges.Nephrol Dial Transplant1988; 3: 198–204.
55.
WangT., ChengH.H., HeimbürgerO., WaniewskiJ., BergströmJ., LindholmB.Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.Kidney Int1998; 53: 496–502.
56.
ColesG.A.Have we underestimated the importance of fluid balance for survival of PD patients.Perit Dial Int1997; 17: 321–6.
57.
DaviesS.J.How to maintain fluid balance in long-term peritoneal dialysis.Perit Dial Int1999; 19(Suppl 2): S332–6.
58.
HartyJ., GokalR.Does CAPD provide adequate dialysis?Nephrol Dial Transplant1995; 10: 1115–17.
59.
PrichardS.Major and minor risk factors for cardiovascular disease in continuous ambulatory peritoneal dialysis patients.Perit Dial Int1999; 19(Suppl 2): S133–7.
LameireN., VanholderR., LooA.V., LambertM.C., VijtD., BockstaeleL.V.Cardiovascular diseases in peritoneal dialysis patients: The size of the problem.Kidney Int Suppl1996; 56: S28–36.
62.
MujaisS., NolphK., GokalR., BlakeP., BurkartJ., ColesG.Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis.Perit Dial Int2000; 20(Suppl 4): S5–21.
63.
FoleyR.N., ParfreyP.S., SarnakM.J.Epidemiology of cardiovascular disease in chronic renal disease.J Am Soc Nephrol1998; 9(12 Suppl): S16–23.
LameireN.H.The impact of residual renal function on the adequacy of peritoneal dialysis.Nephron1997; 77: 13–28.
66.
RottembourgJ.Residual renal function and recovery of renal function in patients treated by CAPD.Kidney Int1993; 43(Suppl 40): S106–10.
67.
LausterF., HeimJ.M., DrummerC., FulleH.J., GerzerR., SchifflH.Plasma cGMP level as a marker of the hydration state in renal replacement therapy.Kidney Int Suppl1993; 41: S57–9.
68.
WuX., PengW.X., YeR.G., MatthieJ., LindholmB., WangT.Fluid status in renal failure patients (Abstract).Perit Dial Int2001; 21(Suppl 1): S83.
69.
PlumJ., SchoenickeG., KleophasW., KulasW., SteffensF., AzemA.Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods.Nephrol Dial Transplant2001; 16: 2378–85.
70.
ChurchillD.N., ThorpeK.E., NolphK.D., KeshaviahP.R., OreopoulosD.G., PagéD.Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients.J Am Soc Nephrol1998; 9: 1285–92.
71.
DaviesS.J., PhillipsL., RussellG.I.Peritoneal solute transport predicts survival on CAPD independently of residual renal function.Nephrol Dial Transplant1998; 13: 962–8.
72.
WangT., HeimbürgerO., WaniewskiJ., BergströmJ., LindholmB.Increased peritoneal permeability is associated with decreased fluid and small solute removal and higher mortality in CAPD patients.Nephrol Dial Transplant1998; 13: 1242–9.
73.
WuX., KongQ.Y., PengW.X., YeR.G., LindholmB., WangT.Increased peritoneal transport rate is associated with fluid overload (Abstract).Perit Dial Int2001; 21(Suppl 2): S40.
74.
HeimbürgerO., WaniewskiJ., WerynskiA., TranæusA., LindholmB.Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity.Kidney Int1990; 38: 495–506.
75.
ColesG.The management of ultrafiltration failure in peritoneal dialysis.Kidney Int Suppl1994; 48: S14–18.
76.
LameireN.Cardiovascular risk factors and blood pressure control in continuous ambulatory peritoneal dialysis.Perit Dial Int1993; 13(Suppl 2): S394–5.
77.
MenonM.K., NaimarkD.M., BargmanJ., VasS.I., OreopoulosD.G.Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function.Nephrol Dial Transplant2001; 16: 2207–13.
78.
LameireN., BernaertP., LambertM.C., VijtD.Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis.Kidney Int Suppl1994; 48: S31–8.
79.
ChungS.H., StenvinkelP., BergströmJ., LindholmB.Biocompatibility of new peritoneal dialysis solutions: What can we hope to achieve?Perit Dial Int2000; 20(Suppl 5): S57–67.
80.
NiebauerJ., VolkH.D., KempM., DominguezM., SchumannR.R., RauchhausM.Endotoxin and immune activation in chronic heart failure: A prospective cohort study.Lancet1999; 353: 1838–42.
81.
KeenM., LippsB., GotchF.The measured creatinine generation rate in CAPD suggests only 78% of the prescribed dialysis is delivered.Adv Perit Dial1993; 9: 73–5.
82.
BlakeP.G.Noncompliance in peritoneal dialysis patients.Perit Dial Int1997; 17: 330–2.
83.
BlakeP.G., KorbetS.M., BlakeR., BargmanJ.M., BurkartJ.M., DelanoB.G.A multicenter study of noncompliance with continuous ambulatory peritoneal dialysis exchanges in US and Canadian patients.Am J Kidney Dis2000; 35: 506–14.
84.
BernardiniJ., PirainoB.Compliance in CAPD and CCPD patients as measured by supply inventories during home visits.Am J Kidney Dis1998; 31: 101–7.
85.
ChurchillD.N., ThorpeK.E., VoneshE.F., KeshaviahP.R.Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. Canada–USA (CANUSA) Peritoneal Dialysis Study Group.J Am Soc Nephrol1997; 8: 965–71.
86.
PeiY.P., GreenwoodC.M., CheryA.L., WuG.G.Racial differences in survival of patients on dialysis.Kidney Int2000; 58: 1293–9.
87.
LaiK.N., LoW.K.Optimal peritoneal dialysis for patients from Hong Kong.Perit Dial Int1999; 19(Suppl 3): S26–31; Discussion: S32–4.
88.
SzetoC.C., LaiK.N., YuA.W., LeungC.B., HoK.K., MakT.W.Dialysis adequacy of Asian patients receiving small volume continuous ambulatory peritoneal dialysis.Int J Artif Organs1997; 20: 428–35.
89.
LoW.K., ChengI.K., LuiS.L., ChanT.M., LiF.K., LaiK.N.Is target Kt/V and patient survival different between Asian and Western continuous ambulatory peritoneal dialysis (CAPD) patients?Perit Dial Int1999; 19(Suppl 2): S27–31.
90.
WangT., WaniewskiJ., HeimbürgerO., WerynskiA., LindholmB.A quantitative analysis of sodium transport and removal during peritoneal dialysis.Kidney Int1997; 52: 1609–16.
91.
WangT., HeimbürgerO., WaniewskiJ., BergströmJ., LindholmB.Time dependence of solute removal during a single exchange.Adv Perit Dial1997; 13: 23–8.
92.
SelgasR., BajoM-A, PaivaA., del PesoG., DiazC., AguileraA.Stability of the peritoneal membrane in long-term peritoneal dialysis patients.Adv Ren Replace Ther1998; 5: 168–78.
93.
DaviesS.J., BryanJ., PhillipsL., RussellG.I.Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis.Nephrol Dial Transplant1996; 11: 498–506.
94.
WoodrowG., OldroydB., StablesG., GibsonJ., TurneyJ.H., BrownjohnA.M.Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis.Nephrol Dial Transplant2000; 15: 862–6.
95.
PosthumaN., VerbrughH.A., DonkerA.J., van DorpW., DekkerH.A., PeersE.M.Peritoneal kinetics and mesothelial markers in CCPD using icodextrin for daytime dwell for two years.Perit Dial Int2000; 20: 174–80.
96.
WoodrowG., StablesG., OldroydB., GibsonJ., TurneyJ.H., BrownjohnA.M.Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis.Nephrol Dial Transplant1999; 14: 1530–5.
97.
MistryC.D., GokalR.The use of glucose polymer (icodextrin) in peritoneal dialysis: An overview.Perit Dial Int1994; 14(Suppl 3): S158–61.
98.
MactierR.A., KhannaR.Absorption of fluid and solutes from the peritoneal cavity: Theoretic and therapeutic implications.ASAIO Trans1989; 35: 122–31.
